Pancreatic Cancer Research

ResearcherInstitut de Cancérologie StrasbourgActive in the last 2 years

Hélène Burckel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9612-5806; OpenAlex author ID A5087771719. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Targeted photodynamic therapy for pancreatic cancer: recent innovations from fundamentals to in vivo and clinical applications (2020-2025). Co-author DOI 10.1039/d5cc05629b↗
  2. Radiosensitizing Pancreatic Cancer with PARP Inhibitor and Gemcitabine: An In Vivo and a Whole-Transcriptome Analysis after Proton or Photon Irradiation. Last author DOI 10.3390/cancers13030527↗
  3. Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines. Last author DOI 10.3390/ijms22136825↗
  4. Targeting DNA repair in combination with radiotherapy in pancreatic cancer: A systematic review of preclinical studies. Last author DOI 10.1016/j.critrevonc.2020.103060↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Waïsse Waïssi · 3 shared papers, 2020–2021 · strength 0.47
  2. Souleymane Sarr · 1 shared paper, 2026 · strength 0.21
  3. Nadira Delhem · 1 shared paper, 2026 · strength 0.21
  4. Gaël S. Roth · 1 shared paper, 2026 · strength 0.21
  5. Anne‐Laure Bulin · 1 shared paper, 2026 · strength 0.21
  6. Vincent Sol · 1 shared paper, 2026 · strength 0.21
  7. Nicolas Jonckheere · 1 shared paper, 2026 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.